Breaking Finance News

Humana Inc (NYSE:HUM) has been downgraded to Hold in a statement by Zacks Investment Research today.

Zacks Investment Research has downgraded Humana Inc (NYSE:HUM) to Hold in a statement released on 6/21/2017.

Displaying a price of $234.90, Humana Inc (NYSE:HUM) traded -0.55% lower on the day. The last stock close price is up 7.68% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has increased 0.04% over the date range. Humana Inc has recorded a 50-day average of $250.25 and a two hundred day average of $231.50. Trading volume was up over the average, with 1,228,357 shares of HUM changing hands over the typical 1,115,220

See Chart Below

Humana Inc (NYSE:HUM)

Humana Inc has 52 week low of $163.50 and a one year high of $259.76 with a price-earnings ratio of 20.51 and has a total market value of $0.

In addition to Zacks Investment Research reporting its stock price target, a total of 15 brokers have issued a research note on the company. The consensus target price is $205.93 with 3 brokerages rating the company a strong buy, three brokerages rating the company a buy, thirteen equity analysts rating the company a hold, zero analysts rating the company a underperform, and lastly zero analysts rating the company a sell.

About Humana Inc (NYSE:HUM)

Humana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *